Literature DB >> 28160007

Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis.

Alarico Ariani1, Mario Silva2, Valeria Seletti2, Elena Bravi3, Marta Saracco4, Simone Parisi5, Fabio De Gennaro6, Luca Idolazzi7, Paola Caramaschi7, Camilla Benini7, Flavio Cesare Bodini8, Carlo Alberto Scirè9, Greta Carrara9, Federica Lumetti10, Veronica Alfieri11, Elisa Bonati11, Gianluca Lucchini1, Marina Aiello11, Daniele Santilli1, Flavio Mozzani1, Davide Imberti3, Emanuele Michieletti8, Eugenio Arrigoni3, Giovanni Delsante1, Raffaele Pellerito4, Enrico Fusaro5, Alfredo Chetta11, Nicola Sverzellati2.   

Abstract

Objective: In this multicentre study, we aimed to evaluate the capacity of a computer-assisted automated QCT method to identify patients with SSc-associated interstitial lung disease (SSc-ILD) with high mortality risk according to validated composite clinical indexes (ILD-Gender, Age, Physiology index and du Bois index).
Methods: Chest CT, anamnestic data and pulmonary function tests of 146 patients with SSc were retrospectively collected, and the ILD-Gender, Age, Physiology score and DuBois index were calculated. Each chest CT underwent an operator-independent quantitative assessment performed with a free medical image viewer (Horos). The correlation between clinical prediction models and QCT parameters was tested. A value of P < 0.05 was considered statistically significant.
Results: Most QCT parameters had a statistically different distribution in patients with diverging mortality risk according to both clinical prediction models (P < 0.01). The cut-offs of QCT parameters were calculated by receiver operating characteristic curve analysis, and most of them could discriminate patients with different mortality risk according to clinical prediction models.
Conclusion: QCT assessment of SSc-ILD can discriminate between well-defined different mortality risk categories, supporting its prognostic value. These findings, together with the operator independence, strengthen the validity and clinical usefulness of QCT for assessment of SSc-ILD.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Horos; OsiriX; interstitial lung disease; mortality risk model.; pulmonary fibrosis; quantitative chest CT; systemic sclerosis

Mesh:

Year:  2017        PMID: 28160007     DOI: 10.1093/rheumatology/kew480

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Quantitative computed tomography detects interstitial lung diseases proven by biopsy.

Authors:  Alarico Ariani; Andrea Imperatori; Massimo Castiglioni; Elisa Daffrè; Marina Aiello; Giuseppina Bertorelli; Alfredo Chetta; Lorenzo Dominioni; Nicola Rotolo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 2.  Pulmonary quantitative CT imaging in focal and diffuse disease: current research and clinical applications.

Authors:  Mario Silva; Gianluca Milanese; Valeria Seletti; Alarico Ariani; Nicola Sverzellati
Journal:  Br J Radiol       Date:  2018-01-12       Impact factor: 3.039

3.  Interstitial lung disease in systemic sclerosis quantification of disease classification and progression with high-resolution computed tomography: An observational study.

Authors:  Johan Clukers; Maarten Lanclus; Dennis Belmans; Cedric Van Holsbeke; Wilfried De Backer; Dharshan Vummidi; Paul Cronin; Ben R Lavon; Jan De Backer; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2021-01-10

4.  Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.

Authors:  Alessandro Maria Ferrazza; Antonietta Gigante; Maria Ludovica Gasperini; Rosa Maria Ammendola; Gregorino Paone; Iacopo Carbone; Edoardo Rosato
Journal:  Clin Rheumatol       Date:  2020-01-15       Impact factor: 2.980

5.  Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis.

Authors:  Marialuisa Bocchino; Dario Bruzzese; Michele D'Alto; Paola Argiento; Alessia Borgia; Annalisa Capaccio; Emanuele Romeo; Barbara Russo; Alessandro Sanduzzi; Tullio Valente; Nicola Sverzellati; Gaetano Rea; Serena Vettori
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

6.  Quantitative assessment of interstitial lung disease in Sjögren's syndrome.

Authors:  Pablo Guisado-Vasco; Mario Silva; Miguel Angel Duarte-Millán; Gianluca Sambataro; Chiara Bertolazzi; Mauro Pavone; Isabel Martín-Garrido; Oriol Martín-Segarra; José Manuel Luque-Pinilla; Daniele Santilli; Domenico Sambataro; Sebastiano E Torrisi; Ada Vancheri; Marwin Gutiérrez; Mayra Mejia; Stefano Palmucci; Flavio Mozzani; Jorge Rojas-Serrano; Carlo Vanchieri; Nicola Sverzellati; Alarico Ariani
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

Review 7.  Predictors of progression in systemic sclerosis patients with interstitial lung disease.

Authors:  Oliver Distler; Shervin Assassi; Vincent Cottin; Maurizio Cutolo; Sonye K Danoff; Christopher P Denton; Jörg H W Distler; Anna-Maria Hoffmann-Vold; Sindhu R Johnson; Ulf Müller Ladner; Vanessa Smith; Elizabeth R Volkmann; Toby M Maher
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

8.  Quantification of Ground Glass Opacities Can Be Useful to Describe Disease Activity in Systemic Sclerosis.

Authors:  Domenico Sambataro; Gianluca Sambataro; Francesca Pignataro; Wanda Maglione; Lorenzo Malatino; Carlo Vancheri; Michele Colaci; Nicoletta Del Papa
Journal:  Diagnostics (Basel)       Date:  2020-04-16

9.  Virtual bronchoscopy using Horos.

Authors:  Atsushi Sano
Journal:  Lung India       Date:  2020 Sep-Oct

Review 10.  Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?

Authors:  Domenico Sambataro; Gianluca Sambataro; Francesca Pignataro; Giovanni Zanframundo; Veronica Codullo; Evelina Fagone; Emanuele Martorana; Francesco Ferro; Martina Orlandi; Nicoletta Del Papa; Lorenzo Cavagna; Lorenzo Malatino; Michele Colaci; Carlo Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.